99
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Fluocinolone Acetonide Intravitreal Implants in Vogt-Koyanagi-Harada Disease

, MD, , BA & , MD, MS
Pages 431-433 | Received 20 May 2009, Accepted 17 Aug 2009, Published online: 09 Dec 2009

REFERENCES

  • Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. 2005;20: 183–190.
  • Rao NA. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents. Ocul Immunol Inflamm. 2006;14: 71–71.
  • Bykhovskaya I, Thorne JE, Kempen JH et al. Vogt-Koyanagi-Harada disease: clinical outcomes. Am J Ophthalmol 2005(140):674–678.
  • Jaffe GJ, McCallum RM, Branchaud B, et al. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology. 2005;112:1192–1198.
  • Callanan DG, Jaffe GJ, Martin DF, et al. Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results. Arch Ophthalmol. 2008;129: 1287–1289.
  • Mahajan VB, Gehrs KM, Goldstein DA, et al. Management of sympathetic ophthalmia with the fluocinolone acetonide implant. Ophthalmology. 2009;116:552–557.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.